Optimizing Prehospital Pathways: Impact of the Iranian Comprehensive Code Stroke Management Program (ICSM Phase III) on Thrombolysis Rates

MedXY Editorial Team•Mar 11, 2026•Clinical Updates

The Iranian Comprehensive Code Stroke Management Program (ICSM Phase III) demonstrated that a multi-faceted empowerment program for EMS can nearly triple the rate of intravenous alteplase administration (from 13.94% to 39.49%).
Standardized prehospital protocols significantly reduced critical time-sensitive intervals, facilitating earlier intervention in the ‘golden hour’ of stroke care.
The study highlights a stark contrast between intervention and control groups, where the latter showed a declining trend in monthly alteplase administrations, emphasizing the necessity of active provider empowerment.
Future iterations of the program require evaluation of long-term functional outcomes (e.g., modified Rankin Scale scores) to validate the clinical efficacy beyond process metrics.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

The Iranian Comprehensive Code Stroke Management Program (ICSM Phase III) demonstrated that a multi-faceted empowerment program for EMS can nearly triple the rate of intravenous alteplase administration (from 13.94% to 39.49%).
Standardized prehospital protocols significantly reduced critical time-sensitive intervals, facilitating earlier intervention in the ‘golden hour’ of stroke care.
The study highlights a stark contrast between intervention and control groups, where the latter showed a declining trend in monthly alteplase administrations, emphasizing the necessity of active provider empowerment.
Future iterations of the program require evaluation of long-term functional outcomes (e.g., modified Rankin Scale scores) to validate the clinical efficacy beyond process metrics.